Download
s00432-021-03629-z.pdf 542,54KB
WeightNameValue
1000 Titel
  • Hormone replacement therapy in BRCA mutation carriers and risk of ovarian, endometrial, and breast cancer: a systematic review
1000 Autor/in
  1. Huber, D. |
  2. Seitz, S. |
  3. Kast, K. |
  4. Emons, G. |
  5. Ortmann, Olaf |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-04-22
1000 Erschienen in
1000 Quellenangabe
  • 147(7):2035-2045
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00432-021-03629-z |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164576/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Purpose!#!BRCA mutation carriers have an increased risk of developing breast or ovarian cancer. Risk-reducing bilateral salpingo-oophorectomy (RRBSO) is associated with a decrease in risk for tubal and ovarian cancer. Hormone replacement therapy (HRT) may increase breast, ovarian, and endometrial cancer risk in the general population. This review analyses the published data on HRT and risk of cancer in BRCA mutation carriers with and without RRBSO.!##!Methods!#!We included all relevant articles published in English from 1995 to October 2020. Sources were identified through a search on PubMed and Cochrane Library.!##!Results!#!We included one case-control and one retrospective cohort study on ovarian and one case-control study on endometrial cancer risk and HRT in BRCA mutation carriers. Regarding breast cancer risk, one case-control study on BRCA mutation carriers with and without RRBSO and one case-control study, one Markov chain decision model, two prospective cohort studies, and one metaanalysis on carriers after RRBSO were included. For ovarian cancer, results were ambiguous. For breast cancer, most studies did not find an adverse effect associated with HRT. However, some of the studies found a risk modification associated with different formulations and duration of use.!##!Conclusion!#!Although data are limited, HRT does not seem to have a relevant effect on cancer risk in BRCA mutation carriers. RRBSO should not be postponed to avoid subsequent HRT in this population. Adequate HRT after RRBSO should be offered to avoid chronic diseases resulting from low estrogen levels. However, further data on the safety of different formulations are needed.
1000 Sacherschließung
lokal
lokal BRCA2 Protein/genetics [MeSH]
lokal Breast Neoplasms/etiology [MeSH]
lokal Genetic Predisposition to Disease [MeSH]
lokal Female [MeSH]
lokal Heterozygote [MeSH]
lokal Mutation [MeSH]
lokal Hormone Replacement Therapy/adverse effects [MeSH]
lokal Ovarian cancer
lokal BRCA1 Protein/genetics [MeSH]
lokal Humans [MeSH]
lokal Breast cancer
lokal Endometrial Neoplasms/etiology [MeSH]
lokal Hormone replacement therapy
lokal Endometrial Neoplasms/pathology [MeSH]
lokal Review – Clinical Oncology
lokal Ovarian Neoplasms/etiology [MeSH]
lokal Breast Neoplasms/pathology [MeSH]
lokal Ovarian Neoplasms/pathology [MeSH]
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/SHViZXIsIEQu|https://frl.publisso.de/adhoc/uri/U2VpdHosIFMu|https://frl.publisso.de/adhoc/uri/S2FzdCwgSy4=|https://frl.publisso.de/adhoc/uri/RW1vbnMsIEcu|https://orcid.org/0000-0001-6238-3949
1000 Hinweis
  • DeepGreen-ID: 6bc58d30e164445ba20128d83d16f03d ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6449882.rdf
1000 Erstellt am 2023-05-09T10:28:33.509+0200
1000 Erstellt von 322
1000 beschreibt frl:6449882
1000 Zuletzt bearbeitet 2023-10-21T02:11:02.416+0200
1000 Objekt bearb. Sat Oct 21 02:11:02 CEST 2023
1000 Vgl. frl:6449882
1000 Oai Id
  1. oai:frl.publisso.de:frl:6449882 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source